1. Home
  2. MTSI vs XOMAO Comparison

MTSI vs XOMAO Comparison

Compare MTSI & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSI
  • XOMAO
  • Stock Information
  • Founded
  • MTSI 1950
  • XOMAO N/A
  • Country
  • MTSI United States
  • XOMAO United States
  • Employees
  • MTSI N/A
  • XOMAO 13
  • Industry
  • MTSI Semiconductors
  • XOMAO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTSI Technology
  • XOMAO Health Care
  • Exchange
  • MTSI Nasdaq
  • XOMAO Nasdaq
  • Market Cap
  • MTSI 9.2B
  • XOMAO N/A
  • IPO Year
  • MTSI 2012
  • XOMAO N/A
  • Fundamental
  • Price
  • MTSI $136.16
  • XOMAO $25.35
  • Analyst Decision
  • MTSI Strong Buy
  • XOMAO
  • Analyst Count
  • MTSI 9
  • XOMAO 0
  • Target Price
  • MTSI $136.56
  • XOMAO N/A
  • AVG Volume (30 Days)
  • MTSI 702.9K
  • XOMAO N/A
  • Earning Date
  • MTSI 07-31-2025
  • XOMAO N/A
  • Dividend Yield
  • MTSI N/A
  • XOMAO N/A
  • EPS Growth
  • MTSI N/A
  • XOMAO N/A
  • EPS
  • MTSI N/A
  • XOMAO N/A
  • Revenue
  • MTSI $845,205,000.00
  • XOMAO N/A
  • Revenue This Year
  • MTSI $33.87
  • XOMAO N/A
  • Revenue Next Year
  • MTSI $12.63
  • XOMAO N/A
  • P/E Ratio
  • MTSI N/A
  • XOMAO N/A
  • Revenue Growth
  • MTSI 32.63
  • XOMAO N/A
  • 52 Week Low
  • MTSI $84.00
  • XOMAO N/A
  • 52 Week High
  • MTSI $152.50
  • XOMAO N/A
  • Technical
  • Relative Strength Index (RSI)
  • MTSI 53.66
  • XOMAO 51.17
  • Support Level
  • MTSI $135.16
  • XOMAO $25.16
  • Resistance Level
  • MTSI $141.75
  • XOMAO $25.65
  • Average True Range (ATR)
  • MTSI 3.66
  • XOMAO 0.11
  • MACD
  • MTSI -1.02
  • XOMAO -0.01
  • Stochastic Oscillator
  • MTSI 24.58
  • XOMAO 38.90

About MTSI MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.

About XOMAO AGNC Investment Corp.

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: